The frequency of detection of cardiovascular diseases among the rural population of the Orenburg region, depending on risk factors

• Nina A. Surikova

Abstract

In Russia, as in the whole world, despite the ongoing therapeutic and preventive measures, cardiovascular diseases (CVD) still occupy the first place in the structure of morbidity and mortality. Risk factors (FR) play a leading role in the development and progression of CVD. To date, more than 300 CVD FRS are known, including both classic and new ones. Cardiovascular morbidity and mortality are associated with a number of socio-economic parameters, such as the level of education, the level of material income and the type of settlement.

The aim of the study – to assess the incidence of new cases of cardiovascular diseases in the rural population of the Orenburg region, depending on the presence or absence of risk factors.

Material and methods. 504 people aged 35 to 75 years participated in the study. The follow-up period was 24 months. The patients’ health status was monitored using a standard questionnaire, clinical blood analysis, levels of glycemia and total cholesterol, and an ECG in 12 standard leads. The assessment of the new cardiovascular events occurrence took place after 2 years. All participants underwent a repeat survey, levels of glycemia and cholesterol control.

Results. The incidence of cardiovascular diseases is associated with risk factors. The most frequent detection of new cases of the disease was in the third group. The most common risk factor associated with CVD is impaired lipid metabolism and arterial hypertension. In the second group, the most common risk factors in the second group were hypercholesterolemia and arterial hypertension, in the third group-obesity and arterial hypertension.

Keywords:arterial hypertension; cardiovascular diseases; rural population

References

1. Shalnova S.A., Deev A.D., Oganov R.G. Factors influencing cardiovascular mortality in Russian population. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention]. 2005; 4 (1): 4–9. (in Russian)

2. Shan M., Jump Z., Lancet E. Urban and Rural Disparities in Tobacco Use. National Conference on Health Statistics. 2012.

3. Boytsov S.A., Demkina A.E. Improving medical care for patients with diseases of the circulatory system in the framework of the Federal project “Combating cardiovascular diseases”. Upravleniye kachestvom v zdravookhranenii [Quality management in healthcare]. 2019; 1: 26–33. (in Russian)

4. Yang Y., Liu F., Wang L., Li Q., Wang X., Chen J.C., Wang Q., Shen H., Zhang Y., Yan D., Zhang M., He Y., Peng Z., Wang Y., Xu J., Zhao J., Zhang Y., Zhang H., Xin X., Wang Y., Liu D., Guo T., Dai Q., Ma X. Association of Husband Smoking With Wife’s Hypertension Status in Over 5 Million Chinese Females Aged 20 to 49 Years. Text : unmediated. J Am Heart Assoc. 2017. 20; 6 (3): e004924. DOI: https://doi.org/10.1161/JAHA.116.004924 PMID: 28320748; PMCID: PMC 5524022.

5. European Cardiovascular Disease Statistics. 2017. URL: http://www.ehnheart.org/cvd-statistics (date of access 10.12.2023)

6. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): casecontrol study. Lancet. 2004; 364 (9438): 937–52.

7. Balanova Ju.A., Deev A.D., Ivanov V.M., et al. The results of the first stage of the epidemiological situation monitoring of arterial hypertension in the Russian Federation (2003–2004.), Carried out in the framework of the federal target program “Prevention and treatment of hypertension in the Russian Federation”. 2005; 15–25. (in Russian)

8. Ford E.S., Zhao G., Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. Text: unmediated. J Am Coll Cardiol. 2010; 55 (13): 1310–7. DOI: https://doi.org/10.1016/j.jacc.2009.10.060

9. Dunlay S.M., Givertz M.M., Aguilar D., et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Text: unmediated. Circulation. 2019; 140 (7): 294–324. DOI: https://doi.org/10.1161/CIR.0000000000000691

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)